Lates News

Medical equipment manufacturer Medtronic announced that its revenue for the third quarter of the 2026 fiscal year increased by 8.7% year-on-year to $9 billion, exceeding market expectations by $1.1 billion; adjusted earnings per share were $1.36, exceeding market expectations by $0.02. The company reiterated its organic revenue growth expectation of approximately 5.5% for the 2026 fiscal year, with adjusted earnings per share expected to be between $5.62 and $5.66, lower than the market's general expectation of $6.12.